News in brief: Myeloma drugs seek PBS listing; Roche leads on haematology drug trials; Infusion sets don’t need replacing so often

Push to have 2 myeloma drugs listed on PBS The Leukaemia Foundation is lobbying for patients with myeloma to have PBS-subisdised access to two new therapies. CEO Chris Tanti says the Foundation is making submissions to PBAC for selinexor (Xpovio) in combination with bortezomib and dexamethasone, to treat relapsed and refractory myeloma, and, separately, in ...

Already a member?

Login to keep reading.

© 2021 the limbic